Science
Mechanism of Action
As a hydrophilic non-ionic surfactant, Poloxamer 407 operates by reducing surface tension, which efficiently solubilizes oil-loving compounds within water-based formulations and facilitates the creation of stable emulsions. Its unique thermoreversible properties allow it to maintain a liquid state at cooler temperatures and transition into a gel upon reaching body temperature, thereby acting as an effective gelling agent. When applied to skin, it assists in cleansing by emulsifying and allowing for the easy rinsing of oils and impurities, and has demonstrated a capacity to promote wound contraction in specific hydrogel contexts.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Proven effective as an emulsifier and thermogelling agent in emulgels, facilitating the controlled release of oil-soluble pharmaceutical actives.
- 02 Incorporated into hydrogel formulations (with chitosan and hyaluronic acid) for the treatment of skin and mucosal wounds, observed to promote wound contraction.
- 03 Utilized in advanced hydrogels for specialized drug delivery applications, including ocular administration and microneedle systems, demonstrating optimal formulation potential.
- 04 A specific gel formulation (LeGoo®) containing Poloxamer 407 received U.S. FDA approval for temporary endovascular occlusion, underscoring its functional reliability and safety.
Transparency
Dusting Analysis
Poloxamer 407 functions as a versatile excipient—a solubilizer, gelling agent, and emulsifier—rather than a primary active ingredient. Therefore, the concept of 'dusting,' typically associated with active ingredients requiring a minimum effective concentration for a direct skin benefit, is not applicable to its functional role.
The Formula
Formulation
Stability
Aqueous solutions of Poloxamer 407 exhibit thermoreversible properties, transitioning from a liquid to a gel state with changes in temperature; for example, a 30% solution gels at room temperature but becomes liquid at 4°C. The optimal gelation temperature for mucoadhesive formulations ranges between 30-36°C. Degradation induced by sonication can lead to toxicity and should be avoided.
Conflicts
- Formulation challenges, including suboptimal compatibility or poor drug solubility, may arise when Poloxamer 407 solutions are combined with certain oily excipients.
- Higher concentrations of Poloxamer 407 in formulations can lead to ocular irritation.
- Aqueous Poloxamer 407 gels may experience a reduction or loss of their gelling ability upon dilution by physiological fluids, such as lachrymal fluid.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has concluded that Poloxamer 407 is safe for use in cosmetics based on current practices and concentrations. While potential concerns regarding impurities like 1,4-dioxane, ethylene oxide, and propylene oxide have been noted, these can be effectively controlled through stringent purification methods. It is recognized by the FDA as an indirect food additive and approved as a pharmaceutical excipient. Animal and clinical tests indicate it causes minimal ocular irritation and no dermal irritation or sensitization.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Poloxamer 407 is a highly valuable, safe, and versatile excipient that significantly enhances formulation stability, solubility, and texture across a broad spectrum of precision skincare and pharmaceutical applications.
Related
Similar Ingredients
Finding similar ingredients…